← Russell 3000 cross-section

DGX QUEST DIAGNOSTICS INC

Trailing twelve months to 2026-06-30 · as filed 2026-07-23, not restated
Healthcare

Scale

Market cap
$27.1bn
Revenue TTM
$11.6bn
Net income TTM
$1.1bn
Free cash flow
$1.3bn
Composite score
57.8
Sector rank
#363

Valuation

P / E
25.6
EV / EBITDA
14.5
EV / sales
2.8
FCF yield
4.97%
Earnings yield vs 10-yr
-0.82pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
9.2%
EBITDA margin
19.1%
ROE
14.1%
ROIC
13.0%
Revenue growth
9.9%

Insider activity, last 90 days

Net open-market
$-3.95m
Buyers
0
Sellers
3

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Management uses number of requisitions and revenue per requisition data to assist with assessing the growth and performance of the business, including understanding trends affecting number of requisitions, pricing and test mix. The Invigorate program aims to deliver 3% annual cost savings and productivity improvements to partially offset pressures from the current inflationary environment, including labor and benefit cost increases and reimbursement pressures. Net Revenues Net revenues for the three months ended June 30, 2026 increased by 10.2% compared to the prior year period principally driven by organic revenue growth of 10.0%. …QUEST DIAGNOSTICS INC, 10-Q, period ended 2026-06-30, filed 2026-07-23

Read the full passage →